Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?

In a former study in patients with severe chronic airflow obstruction (CAO), (forced expiratory volume in one second (FEV1) ranging from 350-910 ml), we concluded that daily oral corticosteroids might slow down the progression of disease. The results of the present long-term (14-20 yr) study on 139 non-allergic patients with less severe CAO (FEV1 greater than or equal to 1200 ml, FEV1 as a percentage of vital capacity (FEV1%VC) 40-55%) confirm and extend our former observations. Four patterns of the course of FEV1 and inspiratory vital capacity (VC) in time were recognized: 1) linear decrease; 2) no change; 3) initial increase, followed by decrease; 4) initial decrease, followed by increase. Groups 1 and 3 had a higher functional residual capacity as a percentage of total lung capacity (FRC%TLC) as compared to group 2 and 4; the work of breathing was lower in group 2 than in the other three groups. Otherwise the initial 82 parameters, including the degree of reversibility of airflow obstruction and smoking habits were comparable in the four groups. The four patterns of FEV1 showed a strong association with the long-term use of prednisolone. When oral prednisolone was instituted or increased to a dose of at least 10 mg/day continuously, FEV1 either remained constant, decreased more slowly or even increased over many years of follow-up. When the oral dose was diminished to below 10 mg/day, FEV1 decreased.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. I. Banauch, C. Hall, M. Weiden, H. W. Cohen, T. K. Aldrich, V. Christodoulou, N. Arcentales, K. J. Kelly, and D. J. Prezant Pulmonary Function after Exposure to the World Trade Center Collapse in the New York City Fire Department Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 312 - 319. [Abstract] [Full Text] [PDF]

				S. Saha, R. Siva, C. E. Brightling, and I. D. Pavord COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition. Eur. Respir. J., April 1, 2006; 27(4): 863 - 865. [Full Text] [PDF]

				J. F. Donohue and J. A. Ohar Effects of Corticosteroids on Lung Function in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 152 - 160. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				M. Decramer, P.N.R. Dekhuijzen, T. Troosters, C. van Herwaarden, M. Rutten-van Molken, C.P.O. van Schayck, D. Olivieri, I. Lankhorst, and A. Ardia The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design Eur. Respir. J., March 1, 2001; 17(3): 329 - 336. [Abstract] [Full Text] [PDF]

				A.M.W.J. Schols, G. Wesseling, A.D.M. Kester, G. de Vries, R. Mostert, J. Slangen, and E.F.M. Wouters Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Eur. Respir. J., March 1, 2001; 17(3): 337 - 342. [Abstract] [Full Text] [PDF]

				K. L. RICE, J. B. RUBINS, F. LEBAHN, C. M. PARENTI, P. G. DUANE, M. KUSKOWSKI, A. M. JOSEPH, and D. E. NIEWOEHNER Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD . A Randomized Trial Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 174 - 178. [Abstract] [Full Text]

				D. S. POSTMA and H. A. M. KERSTJENS Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease? Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S66 - 71. [Abstract] [Full Text] [PDF]

				R. A. Pauwels, C.-G. Lofdahl, L. A. Laitinen, J. P. Schouten, D. S. Postma, N. B. Pride, S. V. Ohlsson, and The European Respiratory Society Study on Chronic Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking N. Engl. J. Med., June 24, 1999; 340(25): 1948 - 1953. [Abstract] [Full Text] [PDF]

				K. D. CLARK, N. WARDROBE-WONG, and P. D. SNASHALL Endogenous Cortisol and Lung Damage in a Predominantly Smoking Population Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 755 - 759. [Abstract] [Full Text]

				P M van Grunsven, C P van Schayck, J P Derenne, H A M Kerstjens, T E J Renkema, D S Postma, T Similowski, R P Akkermans, P C M P.-d. Jong, P N R Dekhuijzen, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis Thorax, January 1, 1999; 54(1): 7 - 14. [Abstract] [Full Text]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				C. P. van Schayck, P. J. J. A. van den Broek, J. J. den Otter, C. L. A. van Herwaarden, J. Molema, and C. van Weel Periodic Treatment Regimens With Inhaled Steroids in Asthma or Chronic Obstructive Pulmonary Disease: Is It Possible? JAMA, July 12, 1995; 274(2): 161 - 164. [Abstract] [PDF]

				G. T. Ferguson and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., April 8, 1993; 328(14): 1017 - 1022. [Full Text]